XML 66 R57.htm IDEA: XBRL DOCUMENT
v3.26.1

Stockholders' Deficit (Additional Information) (Details) |  |  |  |  |  |  |  |  |  |  | 3 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Dec. 11, 2025 $ / shares shares | Nov. 23, 2025 USD ($) $ / shares shares | Sep. 30, 2025 USD ($) $ / shares shares | Dec. 26, 2024 USD ($) | Dec. 11, 2024 USD ($) $ / shares shares | Oct. 27, 2024 USD ($) Days $ / shares shares | Sep. 20, 2024 USD ($) | Apr. 23, 2024 USD ($) $ / shares shares | Feb. 29, 2024 $ / shares shares | Dec. 22, 2023 shares | Mar. 31, 2026 USD ($) $ / shares shares | Mar. 31, 2025 USD ($) shares | Dec. 31, 2025 USD ($) $ / shares shares | Mar. 02, 2026 $ / shares | Feb. 03, 2026 shares
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock Share Price | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 630 |  |  |  |
Stock-based compensation | $ |  |  |  |  |  |  |  |  |  |  | $ 3,629,000 | $ 3,314,000 |  |  |
Additional paid-in capital | $ |  |  |  |  |  |  |  |  |  |  | $ 799,301,000 |  | $ 796,721,000 |  |
Clearing expenses | $ |  |  |  |  |  |  |  | $ 15,950,000 |  |  |  |  |  |  |
Common stock, par value | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 0.0001 |  | $ 0.0001 | $ 0.68 |
Combined Price Paid | $ / shares |  |  |  |  |  |  |  |  | $ 54.74 |  |  |  |  |  |
Warrants outstanding |  |  |  |  |  |  |  |  |  |  | 156,220 |  | 156,220 |  |
Treasury Stock Common Shares Outstanding |  |  |  |  |  |  |  |  |  |  | 1,458,263 |  | 1,458,263 |  |
Common Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding |  |  |  |  |  |  |  |  |  |  | 3,250,000 |  | 3,250,000 |  |
Placement Agent Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Legal fees and expenses | $ |  |  |  |  |  |  |  | $ 100,000 |  |  |  |  |  |  |
Cash fee percentage of gross proceeds paid to placement agents |  |  |  |  |  |  |  | 8.00% |  |  |  |  |  |  |
Warrants outstanding |  |  |  |  |  |  |  |  |  |  | 1,200,000 |  | 1,200,000 |  |
Common Stock [Member] | Placement Agent Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percent of total number of shares issued to agents in the Offering |  |  |  |  |  |  |  | 8.00% |  |  |  |  |  |  |
Series 1 Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trading Days | Days |  |  |  |  |  | 10 |  |  |  |  |  |  |  |  |
Preferred Stock, Dividends Per Share, Declared | $ / shares |  |  |  |  |  | $ 0.0001 |  |  |  |  |  |  |  |  |
Conversion of Stock, Amount Converted | $ |  |  |  |  |  | $ 200,000,000 |  |  |  |  |  |  |  |  |
Preferred Stock Dividends, Shares |  |  |  |  |  | 5,000,000 |  |  |  |  |  |  |  |  |
Treasury Stock Common Shares Outstanding |  |  |  |  |  |  |  |  |  |  | 5,000,000 |  |  |  | 5,000,000
Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Preference shares issue |  |  |  |  |  |  |  |  |  |  | 45,000,000 |  |  |  |
Preferred stock, shares outstanding |  |  |  |  |  |  |  |  |  |  | 29,057,097 |  | 29,057,097 |  |
Rodman & Renshaw LLC |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Public Offering Price | $ / shares |  |  |  |  |  |  |  |  | 59.5 |  |  |  |  |  |
Exercise price of warrant | $ / shares |  |  |  |  |  |  |  |  | $ 59.5 |  |  |  |  |  |
Warrant Purchase |  |  |  |  |  |  |  |  | 168,068 |  |  |  |  |  |
Common stock sold |  |  |  |  |  |  |  |  | 168,068 |  |  |  |  |  |
At-the-Market Sales Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceed's of sale of common shares |  |  |  |  |  |  |  |  |  |  | 3.00% |  |  |  |
Common stock sold |  |  |  |  |  |  |  |  |  |  | 0 | 0 |  |  |
Securities Purchase Agreement | Common Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercisable |  |  |  |  |  |  |  | 34,286 |  |  |  |  |  |  |
Securities Purchase Agreement | Common Stock [Member] | Common Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share (in Dollars per share) | $ / shares |  |  |  |  | $ 20.65 |  |  | $ 35 |  |  |  |  |  |  |
Warrant Inducement Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Received in cash | $ |  | $ 18,600,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant Inducement Agreement | November 2025 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price per share, warrants | $ / shares |  | $ 29 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercised price | $ / shares |  | $ 29 |  |  |  |  |  |  |  |  |  |  |  |  |
Fair Value of the Fee Warrant | $ |  | $ 6,300,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Expiration date |  | Nov. 25, 2030 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant Purchase |  | 1,356,594 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant Inducement Agreement | November 2025 Warrants [Member] | Placement Agent Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price per share, warrants | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 29 |  |  |  |
Warrants exercised price | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 29 |  |  |  |
Warrants exercisable |  |  |  |  |  |  |  |  |  |  | 1,428,946 |  |  |  |
Warrant Purchase |  |  |  |  |  |  |  |  |  |  | 72,352 |  |  |  |
Warrant Exercise Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding |  |  |  |  |  |  |  |  |  |  | 275,000 |  |  |  |
Warrant Exercise Agreement | Common Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number Of Share Outstanding |  |  | 4.99% |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercisable |  |  |  |  |  |  |  |  |  |  | 275,000 |  |  |  |
Deferral fee | $ |  |  | $ 2,700,000 |  |  |  |  |  |  |  |  |  |  |  |
Warrant Exercise Agreement | New Tranche B Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrant | $ / shares |  |  | $ 20 |  |  |  |  |  |  |  |  |  |  |  |
Warrant Purchase |  |  | 275,000 |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from sale of common stock | $ |  |  | $ 2,500,000 |  |  |  |  |  |  |  |  |  |  |  |
Warrant Exercise Agreement | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price per share, warrants | $ / shares |  |  | $ 22.72 |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercised price | $ / shares |  |  | $ 22.72 |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercisable |  |  | 179,236 |  |  |  |  |  |  |  |  |  |  |  |
Deferral fee per share | $ / shares |  |  | $ 7.72 |  |  |  |  |  |  |  |  |  |  |  |
Common stock, par value | $ / shares |  |  | $ 0.0001 |  |  |  |  |  |  |  |  |  |  |  |
Equity Purchase Agreements | November 2025 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant Purchase |  |  |  |  |  |  |  |  |  |  | 1,356,594 |  |  |  |
Repricing Options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation | $ |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,400,000 |  |
Recognized incremental stock-based compensation expense | $ |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,700,000 |  |
Reduction in the exercise prices | $ / shares | $ 16.8 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Unrecognized incremental stock-based compensation expense | $ |  |  |  |  |  |  |  |  |  |  | $ 500,000 |  |  |  |
Maximum | Series 1 Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trading Days | Days |  |  |  |  |  | 15 |  |  |  |  |  |  |  |  |
Maximum | At-the-Market Sales Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of Common Stock Shares Issued |  |  |  |  |  |  |  |  |  | 170,000,000 |  |  |  |  |
Maximum | Warrant Exercise Agreement | Common Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number Of Share Outstanding |  |  | 9.99% |  |  |  |  |  |  |  |  |  |  |  |
Other Noncurrent Liabilities | Placement Agent Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additional paid-in capital | $ |  |  |  |  |  |  |  |  |  |  | $ 600,000 |  |  |  |
Public Warrants Purchase Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price per share, warrants | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 402.5 |  |  |  |
Warrants exercised price | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 402.5 |  |  |  |
2022 Equity Incentive Plan |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price per share, warrants | $ / shares | 282.8 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercised price | $ / shares | 282.8 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved for future issuance |  |  |  |  |  |  |  |  |  |  | 1,051,604 |  |  |  |
2022 Equity Incentive Plan | Repricing Options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price per share, warrants | $ / shares | 282.8 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercised price | $ / shares | $ 282.8 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercisable | 289,405 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Representative Warrants Outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  | 470,588 |  |
Representative Warrants Outstanding | Common Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  | 13,446 |  |
Representative Warrants Outstanding | Other Noncurrent Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additional paid-in capital | $ |  |  | $ 300,000 |  |  |  |  |  |  |  |  |  |  |  |
Firm Warrants [Member] | Securities Purchase Agreement | Common Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number Of Warrants Exercised |  |  |  |  |  |  |  |  |  |  | 0 | 0 |  |  |
Number Of Warrants Exercised |  |  |  |  |  |  |  |  |  |  | 3,803,447 |  | 108,686 |  |
Exercise price of warrant | $ / shares |  |  |  |  | $ 20.65 |  |  |  |  |  |  |  |  |  |
Warrant Purchase |  |  |  |  | 50,421 |  |  |  |  |  |  |  |  |  |
Registered Direct Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from warrant exercises | $ |  |  |  | $ 200,000 |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrant | $ / shares |  |  |  |  |  |  |  | $ 38.5 |  |  |  |  |  |  |
Registered Direct Offering | Common Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercisable |  |  |  |  | 1,642,871 |  |  |  |  |  | 537,298 |  | 131,472 |  |
Warrants outstanding |  |  |  |  |  |  |  |  |  |  | 537,298 |  |  |  |
Registered Direct Offering | Placement Agent Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additional paid-in capital | $ |  |  |  | $ 600,000 |  |  |  |  |  |  |  |  |  |  |
Percent of combined offering exercise price per share |  |  |  |  |  |  |  | 125.00% |  |  |  |  |  |  |
Warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  | 131,472 |  |
Exercise price of warrant | $ / shares |  |  |  |  |  |  |  | $ 43.75 |  |  |  |  |  |  |
Registered Direct Offering | Common Stock [Member] | Placement Agent Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercisable |  |  |  |  |  |  |  | 34,286 |  |  |  |  |  |  |
Registered Direct Offering | Securities Purchase Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds from offering | $ |  |  |  |  |  |  |  | $ 15,000,000 |  |  |  |  |  |  |
Registered Direct Offering | Securities Purchase Agreement | Common Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Pre-funded warrants to purchase |  |  |  |  | 92,857 |  |  |  |  |  |  |  |  |  |
Registered Direct Offering | Securities Purchase Agreement | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued, shares |  |  |  |  | 68,604 |  |  | 428,572 |  |  |  |  |  |  |
Registered Direct Offering | Securities Purchase Agreement | Common Stock [Member] | Common Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Pre funded warrant per share | $ / shares |  |  |  |  | $ 20.6499 |  |  |  |  |  |  |  |  |  |
Registered Direct Offering | Warrant Inducement Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Reduction in the exercise prices | $ / shares |  | $ 38.5 |  |  |  |  |  |  |  |  |  |  |  |  |
Registered Direct Offering | Warrant Inducement Agreement | April 2024 RDO Common Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Reduction in the exercise prices | $ / shares |  | $ 22.72 |  |  |  |  |  |  |  |  |  |  |  |  |
Registered Direct Offering | Warrant Inducement Agreement | November 2025 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issue of warrants |  | 904,396 |  |  |  |  |  |  |  |  |  |  |  |  |
Registered Direct Offering | Warrant Inducement Agreement | December 2024 RDO Common Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Reduction in the exercise prices | $ / shares |  | $ 22.51 |  |  |  |  |  |  |  |  |  |  |  |  |
Treasury Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Treasury Stock Common Shares Outstanding |  |  |  |  |  |  |  |  |  |  | 1,458,263 |  | 1,458,263 |  |
SPAC Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Repurchase of warrants | $ |  |  |  |  |  |  | $ 4,000,000 |  |  |  |  |  |  |  |
SPAC Warrants [Member] | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Repurchase of warrants | $ |  |  |  |  |  |  | $ 4,000,000 |  |  |  |  |  |  |  |
Public Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price per share, warrants | $ / shares |  |  |  |  |  |  |  |  | $ 74.38 |  |  |  |  |  |
Warrants exercised price | $ / shares |  |  |  |  |  |  |  |  | $ 74.38 |  |  |  |  |  |
Public Warrant [Member] | Warrant Transfer Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price per share, warrants | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 0.01 |  |  |  |
Warrants exercised price | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 0.01 |  |  |  |
Warrants outstanding |  |  |  |  |  |  |  |  |  |  | 1,000,000 |  | 28,572 |  |
Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved for future issuance |  |  |  |  |  |  |  |  | 13,446 |  |  |  |  |  |
Public Offering Price Combined |  |  |  |  |  |  |  |  | 125.00% |  |  |  |  |  |
Warrant [Member] | Registered Direct Offering | Securities Purchase Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from warrant exercises | $ |  |  |  |  | $ 17,000,000 |  |  |  |  |  |  |  |  |  |

X
- Definition Aggregate Gross Proceeds From Offering + References No definition available. + Details
Name: | sclx_AggregateGrossProceedsFromOffering
Namespace Prefix: | sclx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash Fee Percentage of Gross Proceeds Paid to Placement Agents + References No definition available. + Details
Name: | sclx_CashFeePercentageOfGrossProceedsPaidToPlacementAgents
Namespace Prefix: | sclx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Clearing Expenses + References No definition available. + Details
Name: | sclx_ClearingExpenses
Namespace Prefix: | sclx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Combined Price Paid Of Warrant + References No definition available. + Details
Name: | sclx_CombinedPricePaidOfWarrant
Namespace Prefix: | sclx_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Common stock sold. + References No definition available. + Details
Name: | sclx_CommonStockSold
Namespace Prefix: | sclx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Deferral Fee + References No definition available. + Details
Name: | sclx_DeferralFee
Namespace Prefix: | sclx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Deferral Fee Per Share + References No definition available. + Details
Name: | sclx_DeferralFeePerShare
Namespace Prefix: | sclx_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise Price Of Common Warrant + References No definition available. + Details
Name: | sclx_ExercisePriceOfCommonWarrant
Namespace Prefix: | sclx_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Issue of Warrants to Purchase Shares + References No definition available. + Details
Name: | sclx_IssueOfWarrantsToPurchaseShares
Namespace Prefix: | sclx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number Of Share Outstanding + References No definition available. + Details
Name: | sclx_NumberOfShareOutstanding
Namespace Prefix: | sclx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number Of Warrants Exercised + References No definition available. + Details
Name: | sclx_NumberOfWarrantsExercised
Namespace Prefix: | sclx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number Of Warrants Exercised 1 + References No definition available. + Details
Name: | sclx_NumberOfWarrantsExercised1
Namespace Prefix: | sclx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percent of Combined Offering Exercise Price Per Share + References No definition available. + Details
Name: | sclx_PercentOfCombinedOfferingExercisePricePerShare
Namespace Prefix: | sclx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percent of Total Number of Shares issued to Agents in the Offering + References No definition available. + Details
Name: | sclx_PercentOfTotalNumberOfSharesIssuedToAgentsInTheOffering
Namespace Prefix: | sclx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Pre Funded Warrant Per Share + References No definition available. + Details
Name: | sclx_PreFundedWarrantPerShare
Namespace Prefix: | sclx_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Pre Funded Warrants to Purchase + References No definition available. + Details
Name: | sclx_PreFundedWarrantsToPurchase
Namespace Prefix: | sclx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Proceed s of sale of common shares percentage + References No definition available. + Details
Name: | sclx_ProceedSOfSaleOfCommonSharesPercentage
Namespace Prefix: | sclx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Proceeds from sale of common stock. + References No definition available. + Details
Name: | sclx_ProceedsFromSaleOfCommonStock
Namespace Prefix: | sclx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Public Offering Price + References No definition available. + Details
Name: | sclx_PublicOfferingPrice
Namespace Prefix: | sclx_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Public Offering Price Combined + References No definition available. + Details
Name: | sclx_PublicOfferingPriceCombined
Namespace Prefix: | sclx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Purchase Of Common Warrants + References No definition available. + Details
Name: | sclx_PurchaseOfCommonWarrants
Namespace Prefix: | sclx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Recognized Incremental Stock Based Compensation Expense + References No definition available. + Details
Name: | sclx_RecognizedIncrementalStockBasedCompensationExpense
Namespace Prefix: | sclx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Shareholders Equity Details Line Items + References No definition available. + Details
Name: | sclx_ShareholdersEquityDetailsLineItems
Namespace Prefix: | sclx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Unrecognized Incremental Stock Based Compensation Expense + References No definition available. + Details
Name: | sclx_UnrecognizedIncrementalStockBasedCompensationExpense
Namespace Prefix: | sclx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)(a)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_AdditionalPaidInCapital
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants or rights outstanding. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate number of common shares reserved for future issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5 + Details
Name: | us-gaap_ConversionOfStockAmountConverted1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentConvertibleThresholdTradingDays
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1D -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D + Details
Name: | us-gaap_DeferredFinanceCostsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 + Details
Name: | us-gaap_FairValueAdjustmentOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Subparagraph (k) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(6)) -SubTopic 10 -Topic 220 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_LegalFees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Date the credit facility terminates, in YYYY-MM-DD format. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(19)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_LineOfCreditFacilityExpirationDate1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 15 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15 + Details
Name: | us-gaap_PaymentsForRepurchaseOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Per share decrease in conversion price of convertible preferred stock. Excludes change due to standard antidilution provision. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 + Details
Name: | us-gaap_PreferredStockConvertibleConversionPriceDecrease
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Aggregate dividends declared during the period for each share of preferred stock outstanding. + References No definition available. + Details
Name: | us-gaap_PreferredStockDividendsPerShareDeclared
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares of preferred stock issued as dividends during the period. Excludes stock splits. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_PreferredStockDividendsShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 + Details
Name: | us-gaap_PreferredStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 + Details
Name: | us-gaap_PreferredStockSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromWarrantExercises
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of noncash expense for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 + Details
Name: | us-gaap_ShareBasedCompensation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Price of a single share of a number of saleable stocks of a company. + References No definition available. + Details
Name: | us-gaap_SharePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of previously issued common shares repurchased by the issuing entity and held in treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1 + Details
Name: | us-gaap_TreasuryStockCommonShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=sclx_CommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=sclx_PlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=sclx_SeriesOnePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=sclx_RodmanRenshawLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sclx_PurchaseAgreementAxis=sclx_AtTheMarketSalesAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DeferredRevenueArrangementTypeAxis=sclx_SecuritiesPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=sclx_WarrantInducementAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=sclx_November2025WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=sclx_WarrantExerciseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=sclx_NewTrancheBWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=sclx_EquityPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=sclx_RepricingOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=sclx_PublicWarrantsPurchaseCommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=sclx_TwoThousandTwentyTwoEquityIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=sclx_RepresentativeWarrantsOutstandingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=sclx_FirmWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=sclx_RegisteredDirectOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=sclx_April2024RDOCommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=sclx_December2024RDOCommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=sclx_SpacWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=sclx_PublicWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=sclx_WarrantTransferAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |